DRKS00005458已完成未知
Spectrophotometric analysis of fluorescent zirconia abutments compared to conventional” zirconia abutments: a within subject controlled clinical trial - 3M ESPE
niversität Zürich, Zentrum für Zahnmedizin, Klinik für Rekonstruktive Zahnmedizin0 个研究点目标入组 20 人开始时间: 2013年11月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Male and female patients from 18-80 years of age
- •Single-tooth Straumann Bone Level in the anterior maxilla or mandible (incisors, canines, premolars)
- •At least one natural tooth present (contralateral control tooth)
- •Informed consent signed
排除标准
- •Smoking more than 15 cigarettes a day
- •Poor oral hygiene (Plaque Index and/or bleeding on probing over 30%)
- •Probing depth greater than 4 mm
- •Oral mucosa diseases
- •Pregnancy at the date of inclusion
研究者
相似试验
尚未招募
不适用
Molecular Imaging of Zirconium-89-labeled Brentuximab as a Tool to Investigate brentuximab biodistribution in CD30-positive LymphomaHodgkin lymphomaNL-OMON51758niversitair Medisch Centrum Groningen20
进行中（未招募）
1 期
Imaging with a radioactively-labeled antibody against PDL-1 in patients with lymphomaDiffuse large B-cell LymphomaMedDRA version: 20.0 Level: HLT Classification code 10012819 Term: Diffuse large B-cell lymphomas System Organ Class: 100000004851MedDRA version: 20.0 Level: PT Classification code 10012818 Term: Diffuse large B-cell lymphoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: LLT Classification code 10012820 Term: Diffuse large B-cell lymphoma NOS System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-003511-20-NLHOVON Foundation20
尚未招募
2 期
Molecular imaging of zirconium-89-labeled atezolizumab as a tool to investigate atezolizumab biodistribution in diffuse large B-cell lymphomadiffuse large B-cell lymphomalymphomaNL-OMON48775HOVO20
招募中
不适用
se of Fluorescence spectroscopy in clinical diagnosis of different skin conditionsCTRI/2017/01/007625Prin L N Welingkar Institute of Management Development and Research300
尚未招募
2 期
A Phase IIB, Open Label, Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET-CT in Subjects with Selected Advanced or Metastatic Malignancies including Melanoma, Merkel Cell, Renal Cell and Non-Small Cell Lung Cancers, Scheduled to Receive Standard-of-Care Immunotherapy (IOT) as a Single Agent or Combination, to Predict Response to TherapyNL-OMON54060ImaginAb, Inc.30